Breast implant-associated anaplastic large-cell lymphoma: A case report and a review of literature

Abstract

Breast implant-associated anaplastic large-cell lymphoma will be identified as a separate nosological entity in the 2017 adapted WHO classification due to differences in its clinical presentations, pathogenesis, and prognosis with those of nodal and cutaneous anaplastic large-cell lymphomas. The paper gives a review of the literature and describes the authors’ own clinical case of common breast implant-associated anaplastic large-cell lymphoma involving breast tissue, axillary lymph nodes, anterior chest muscles, and bone marrow. The treatment policy chosen by the authors could achieve complete remission.

Keywords

• breast implant-associated anaplastic large-cell lymphoma
• textured silicone implants
• high-dose chemotherapy
• autologous hematopoietic cell transplantation